{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:54:05Z","timestamp":1786974845474,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010313","name":"Heidelberg Engineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xops.2026.101106","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T01:16:01Z","timestamp":1770254161000},"page":"101106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Mai","family":"Alhelaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Soylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Oncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Corradetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6309-127X","authenticated-orcid":false,"given":"Keren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-5050","authenticated-orcid":false,"given":"Nicholas J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivakumar R.","family":"Rathinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-9793","authenticated-orcid":false,"given":"John A.","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Thundikandy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha Vadakke","family":"Kanakath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-6227","authenticated-orcid":false,"given":"S. Bala","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Vedhanayaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-685X","authenticated-orcid":false,"given":"Lyndell L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0621-1234","authenticated-orcid":false,"given":"Hassan A.","family":"Al-Dhibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-8834","authenticated-orcid":false,"given":"Srinivas R.","family":"Sadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Madow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-0519","authenticated-orcid":false,"given":"Alison B.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-9191","authenticated-orcid":false,"given":"Edmund","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2026.101106_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis: a potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2026.101106_bib2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.semarthrit.2019.06.004","article-title":"New observations and emerging ideas in diagnosis and management of non-infectious uveitis: a review","volume":"49","author":"Rosenbaum","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.xops.2026.101106_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273940903348835","article-title":"Are the Standardization of the Uveitis Nomenclature (SUN) working group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN working group classification","volume":"18","author":"Khairallah","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101106_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13023-015-0318-6","article-title":"Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis","volume":"10","author":"Denniston","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.xops.2026.101106_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1745-6215-13-132","article-title":"Developing core outcome sets for clinical trials: issues to consider","volume":"13","author":"Williamson","year":"2012","journal-title":"Trials"},{"key":"10.1016\/j.xops.2026.101106_bib7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.ophtha.2014.02.018","article-title":"Interobserver agreement in clinical grading of vitreous haze using alternative grading scales","volume":"121","author":"Hornbeak","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101106_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ajo.2008.06.004","article-title":"Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib9","doi-asserted-by":"crossref","first-page":"BIO131","DOI":"10.1167\/iovs.17-21788","article-title":"Biomarkers and surrogate endpoints in uveitis: the impact of quantitative imaging","volume":"58","author":"Denniston","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101106_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273948.2020.1799038","article-title":"Noninvasive instrument-based tests for detecting and measuring vitreous inflammation in uveitis: a systematic review","volume":"30","author":"Liu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101106_bib11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/09273948.2022.2075399","article-title":"The Vitreous in uveitis: characterizing the invisible with optical coherence tomography","volume":"30","author":"Pichi","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101106_bib12","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/jcm12113746","article-title":"Diagnosis, classification, and assessment of the underlying etiology of Uveitis by artificial intelligence: a systematic review","volume":"12","author":"Jacquot","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2026.101106_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajo.2022.08.025","article-title":"Objective quantification of posterior segment inflammation: measuring vitreous cells and haze using optical coherence tomography","volume":"245","author":"Zicarelli","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib14","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.ophtha.2014.03.006","article-title":"Objective measurement of vitreous inflammation using optical coherence tomography","volume":"121","author":"Keane","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101106_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/bjophthalmol-2015-308008","article-title":"Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-tenon\u2019s triamcinolone acetonide for uveitic cystoid macular oedema","volume":"101","author":"Sreekantam","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib16","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1097\/IAE.0000000000003190","article-title":"Automated quantification of vitreous hyperreflective foci and vitreous haze using optical coherence tomography in patients with uveitis","volume":"41","author":"Lee","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.xops.2026.101106_bib17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1167\/tvst.4.5.4","article-title":"Automated analysis of vitreous inflammation using spectral-domain optical coherence tomography","volume":"4","author":"Keane","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2026.101106_bib18","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1007\/s00417-017-3689-7","article-title":"Retinal pigmentary changes in chronic uveitis mimicking retinitis pigmentosa","volume":"255","author":"Sevgi","year":"2017","journal-title":"Graefe's Archive Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib19","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1167\/iovs.18-24143","article-title":"Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression","volume":"59","author":"Nassisi","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101106_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.11.1.3","article-title":"OCT assisted quantification of vitreous inflammation in uveitis","volume":"11","author":"Liu","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2026.101106_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jama.2019.12618","article-title":"Effect of corticosteroid-sparing treatment with Mycophenolate Mofetil vs methotrexate on inflammation in patients with uveitis: a randomized clinical trial","volume":"322","author":"Rathinam","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2026.101106_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ophtha.2022.02.002","article-title":"Outcomes of uveitic macular edema in the first-line antimetabolites as steroid-sparing treatment uveitis trial","volume":"129","author":"Tsui","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2026.101106_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/09273948.2023.2165949","article-title":"Reduced dose methotrexate and mycophenolate Mofetil in noninfectious uveitis: a sub-analysis from the first-line antimetabolites as steroid sparing therapy (FAST) trial","volume":"32","author":"Sura","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.xops.2026.101106_bib24","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1167\/iovs.09-4325","article-title":"Impact of scanning density on measurements from spectral domain optical coherence tomography","volume":"51","author":"Sadda","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101106_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1167\/iovs.06-0554","article-title":"Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading","volume":"48","author":"Sadda","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2026.101106_bib26","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41598-018-20092-y","article-title":"Optimizing OCT acquisition parameters for assessments of vitreous haze for application in uveitis","volume":"8","author":"Montesano","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2026.101106_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jcjo.2020.04.003","article-title":"Quantifying vitreous inflammation in uveitis: an optical coherence tomography prospective study","volume":"55","author":"Barbosa","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ajo.2015.10.009","article-title":"Evaluation of objective vitritis grading method using optical coherence tomography: influence of phakic status and previous vitrectomy","volume":"161","author":"Zarranz-Ventura","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib29","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjo.2004.097022","article-title":"Influence of cataract on optical coherence tomography image quality and retinal thickness","volume":"90","author":"Van Velthoven","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2026.101106_bib30","first-page":"1574","article-title":"Changes in retinal nerve fiber layer thickness measurements in response to a trifocal intraocular lens implantation","volume":"32","author":"Garc\u00eda-Bella","year":"2018","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.xops.2026.101106_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.1.2","article-title":"In vivo measurement of the human vitreous chamber volume using computed tomography imaging of 100 eyes","volume":"9","author":"Azhdam","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2026.101106_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ajo.2008.09.024","article-title":"High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading","volume":"147","author":"Agarwal","year":"2009","journal-title":"Am J Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914526000448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T08:24:17Z","timestamp":1776241457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914526000448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666914526000448"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2026.101106","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2026.101106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101106"}}